Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

How Big Is Vertex's News for Its Potential Diabetes Cure?


Vertex Pharmaceuticals (NASDAQ: VRTX) recently announced positive results from an early stage clinical study of cell therapy VX-880 in treating type 1 diabetes. In this Motley Fool Live video recorded on Oct. 20, Fool.com contributors Keith Speights and Brian Orelli discuss the significance of this news for an experimental drug that has been referred to as a potential cure for type 1 diabetes.

Continue reading


Source Fool.com

Like: 0
Share

Comments